Skip to Content

ASCO 2019: Maintenance Therapy with PARP Inhibitor Olaparib Delays Progression of BRCA-related Pancreatic Cancer

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top